Attenua Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Attenua General Information

Description

Developer of medicines intended for patients who suffer from chronic respiratory disorders. The company develops novel medicines for patients who suffer from chronic respiratory disorders such as chronic cough, enabling patients to live a healthy life.

Contact Information

Website
www.attenua.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • C/o Benjamin Potter/Latham and Watkins, 140 Scott Drive
  • Menlo Park, CA 94025
  • United States
+1 (650)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • C/o Benjamin Potter/Latham and Watkins, 140 Scott Drive
  • Menlo Park, CA 94025
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Attenua Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 05-Feb-2020 Completed Clinical Trials - Phase 2
1. Early Stage VC (Series A) 30-Apr-2018 Completed Clinical Trials - Phase 2
To view Attenua’s complete valuation and funding history, request access »

Attenua Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A2
Series A1
To view Attenua’s complete cap table history, request access »

Attenua Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of medicines intended for patients who suffer from chronic respiratory disorders. The company develops novel m
Drug Discovery
Menlo Park, CA

Stevenage, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Attenua Competitors (1)

One of Attenua’s competitors is NeRRe Therapeutics, a Venture Capital-Backed company based in Stevenage, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NeRRe Therapeutics Venture Capital-Backed Stevenage, United Kingdom
You’re viewing 1 of 1 competitors. Get the full list »

Attenua Patents

Attenua Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2018152554-A1 Antitussive compositions and methods Inactive 22-May-2017
WO-2017070235-A1 Antitussive compositions and methods Inactive 19-Oct-2015
AU-2016302769-A1 Antitussive compositions and methods Inactive 31-Jul-2015
CA-2994150-A1 Antitussive compositions and methods Inactive 31-Jul-2015
EP-3328383-A1 Antitussive compositions and methods Inactive 31-Jul-2015 A61K31/439
To view Attenua’s complete patent history, request access »

Attenua Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Abingworth Venture Capital Minority
Omega Funds Venture Capital Minority
OrbiMed Growth/Expansion Minority
Redmile Group Venture Capital Minority
To view Attenua’s complete investors history, request access »

Attenua Investments (1)

Attenua’s most recent deal was a Corporate Asset Purchase with Catalyst Biosciences (oral neural nicotinic receptor assets) for . The deal was made on 01-Aug-2016.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Catalyst Biosciences (oral neural nicotinic receptor assets) 01-Aug-2016 Corporate Asset Purchase Buildings and Property
To view Attenua’s complete investments history, request access »

Attenua FAQs

  • When was Attenua founded?

    Attenua was founded in 2015.

  • Where is Attenua headquartered?

    Attenua is headquartered in Menlo Park, CA.

  • What industry is Attenua in?

    Attenua’s primary industry is Drug Discovery.

  • Is Attenua a private or public company?

    Attenua is a Private company.

  • What is Attenua’s current revenue?

    The current revenue for Attenua is .

  • How much funding has Attenua raised over time?

    Attenua has raised $35M.

  • Who are Attenua’s investors?

    Abingworth, Omega Funds, OrbiMed, and Redmile Group have invested in Attenua.

  • Who are Attenua’s competitors?

    NeRRe Therapeutics is a competitor of Attenua.

  • When was Attenua acquired?

    Attenua was acquired on 05-Feb-2020.

  • Who acquired Attenua?

    Attenua was acquired by Coda Biotherapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process